Given the prevalence of cardiovascular disease, type 2 diabetes, chronic kidney disease, and metabolic syndrome, it seems plausible that GLP1s reduce all-cause mortality
Hims & Hers has a long history of providing safe access to personalized healthcare to millions of Americans, and we will continue to fight to provide choice, affordability, and access. Once again, Big Pharma is weaponizing the US judicial system to limit consumer choice
Emerging evidence suggests a possible physiologic role for GLP-1 in regulating food intake
In Conclusion: The Path Forward GLP-1 medications offer valuable health benefits beyond weight loss, including improved heart health, better blood sugar control, and reduced inflammation
Trends Endocrinol Metab 22:2433 Tiano JP, Delghingaro-Augusto V, Le May C et al (2011) Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents beta cell failure in rodent models of type 2 diabetes
The FDA recently approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of heart attack, cardiovascular death and stroke